This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Universitéde Liége, University of Florida Research Foundation Inc.. Active years: 2019.
Company Filing History:


Years Active: 2019
Title: Innovations of Sebastien Rigali in Thaxtomin Production
Introduction
Sebastien Rigali is an accomplished inventor based in Esneux, Belgium. He has made significant contributions to the field of biotechnology, particularly in the production of thaxtomin, a compound of interest in agricultural applications. His innovative work has led to the development of genetically modified bacteria that enhance thaxtomin production.
Latest Patents
Sebastien Rigali holds a patent titled "Methods for thaxtomin production and modified streptomyces with increased thaxtomin production." This patent describes methods involving genetically modified bacteria capable of increased thaxtomin production. The invention includes modifications to the CebR protein and the β-glucosidase enzyme, which are crucial for optimizing thaxtomin yield. His patent represents a significant advancement in the methods of producing this valuable compound.
Career Highlights
Throughout his career, Sebastien Rigali has worked with prestigious institutions such as the Université de Liège and the University of Florida Research Foundation Inc. His research has focused on enhancing agricultural productivity through biotechnological innovations. His expertise in genetic modification has positioned him as a key figure in the field.
Collaborations
Sebastien has collaborated with notable colleagues, including Isolde Maria Francis and Samuel Jourdan. These partnerships have fostered a collaborative environment that has led to groundbreaking research and development in thaxtomin production.
Conclusion
Sebastien Rigali's contributions to the field of biotechnology, particularly in thaxtomin production, highlight his innovative spirit and dedication to advancing agricultural science. His work continues to influence the industry and pave the way for future innovations.